Crisylis Bioworks Private Limited - Company Profile

It is a professional services private limited company based in Pune City, Maharashtra, India, established in 2024.
2024 Pune City, Maharashtra, India Active
Last Updated:
About Crisylis Bioworks Private Limited

Crisylis Bioworks Private Limited, a active private limited company, was established on 26 February 2024 in Pune City, Maharashtra, India. Engaging in hardware consulting within the professional services sector, it holds CIN: U72100PN2024PTC228573. Registered under ROC Roc Pune. it is unlisted. It has an authorized capital of ₹0.10 M and a paid-up capital of ₹10.00 K .

Its leadership includes Kedar Madhav Kulkarni (Director), Chitra Kedar Kulkarni (Director). Past directors included Shreya Kedar Kulkarni. Its latest AGM occurred on 09 December 2025, with the balance sheet filed on 31 March 2025. It is based at F.No3 Pushkaraj Apt Kohin, Oor Colony Sahakarnagar 2, Pune City, Maharashtra, 411009.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U72100PN2024PTC228573

  • Registration Number

    228573

  • Incorporation Date

    26 February 2024

  • Authorized Capital

    ₹0.10 M

  • Paid-Up Capital

    ₹10.00 K

  • ROC Code

    Roc Pune

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 0.10 M
  • Paid Up Capital ₹ 10.00 K
  • Company Age 2 Year, 4 Months
  • Last Filing with ROC 31 Mar 2025
Company report

Crisylis Bioworks Private Limited

Company Report FY 2026-2027

Comprehensive Company Insights

Explore comprehensive insights into Crisylis Bioworks Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Crisylis Bioworks Private Limited?
Current Directors
Name Designation Appointment Date Status
Kedar Madhav Kulkarni Director 26 Feb 2024 Current
Chitra Kedar Kulkarni Director 26 Feb 2024 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Director - Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Crisylis Bioworks.

Enhance accessibility to Crisylis Bioworks's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.

Crisylis Bioworks revenue growth over time
Crisylis Bioworks profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
*******
*******
*******
*******
*******
Profit or Loss
*******
*******
*******
*******
*******
*******
Net Worth
*******
*******
*******
*******
*******
*******
EBITDA
*******
*******
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Crisylis Bioworks?

Unlock access to Crisylis Bioworks's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Crisylis Bioworks?

Unlock and access historical data on people associated with Crisylis Bioworks, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Crisylis Bioworks, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Crisylis Bioworks's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Crisylis Bioworks
Recent Activity within the Organization
  • Annual General Meeting

    The activity Crisylis Bioworks Private Limited last Annual general meeting of members was held on 09 Dec 2025 as per latest MCA records. was completed.

  • Balance Sheet

    Crisylis Bioworks Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Pune. was recorded as a recent event.

  • Director Appointment

    The activity Kedar Madhav Kulkarni was appointed as a Director was appointed as a Director on 26 Feb 2024 & has been associated with this company since 2 years 4 months . was completed.

  • Director Appointment

    The activity Chitra Kedar Kulkarni was appointed as a Director was appointed as a Director on 26 Feb 2024 & has been associated with this company since 2 years 4 months . was completed.

  • Company Incorporation

    The activity Crisylis Bioworks Private Limited was registered on 26 Feb 2024 with Roc Pune & aged 2 years 4 months as per MCA records. was completed.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Crisylis Bioworks Private Limited?

The CIN of Crisylis Bioworks Private Limited is U72100PN2024PTC228573.

Where is Crisylis Bioworks Private Limited headquartered?

Crisylis Bioworks Private Limited is headquartered at F.No3 Pushkaraj Apt Kohin, Oor Colony Sahakarnagar 2, Pune City, Maharashtra, 411009.

When was Crisylis Bioworks Private Limited incorporated?

Crisylis Bioworks Private Limited was incorporated on 26 February 2024.

Who are the current directors of Crisylis Bioworks Private Limited?

The current directors of Crisylis Bioworks Private Limited are

What is the primary industry of Crisylis Bioworks Private Limited?

The primary industry of Crisylis Bioworks Private Limited is Professional Services.

Is Crisylis Bioworks Private Limited a listed company?

Crisylis Bioworks Private Limited is unlisted.

What is the capital structure of Crisylis Bioworks Private Limited?

The authorized capital of Crisylis Bioworks Private Limited is ₹0.10 M, and the paid-up capital is ₹10.00 K .

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available